Peptide data,
turned into evidence.
Global verification findings and price benchmarks are calculated from the same dated records as the public pages and downloads. A chart cannot quietly outlive, omit, or rewrite its source rows.
COA routes, organized by the peptide name people search.
These 13 product hubs exist only where the current public ledger contains at least three document routes. They compare batch labels, laboratories, dates, field visibility, and original sources without inventing a quality score.
Retatrutide
27 public reports- Displayed batches
- 26
- Named labs
- 3
- Quantity shown
- 25
GHK-Cu
9 public reports- Displayed batches
- 9
- Named labs
- 3
- Quantity shown
- 9
MOTS-c
9 public reports- Displayed batches
- 9
- Named labs
- 3
- Quantity shown
- 9
Semaglutide
9 public reports- Displayed batches
- 8
- Named labs
- 3
- Quantity shown
- 0
BPC-157
6 public reports- Displayed batches
- 6
- Named labs
- 3
- Quantity shown
- 6
NAD+
6 public reports- Displayed batches
- 6
- Named labs
- 3
- Quantity shown
- 4
TB-500
6 public reports- Displayed batches
- 6
- Named labs
- 3
- Quantity shown
- 6
Tesamorelin
6 public reports- Displayed batches
- 6
- Named labs
- 3
- Quantity shown
- 2
Melanotan I
5 public reports- Displayed batches
- 5
- Named labs
- 2
- Quantity shown
- 3
Selank
4 public reports- Displayed batches
- 4
- Named labs
- 2
- Quantity shown
- 4
Ipamorelin
3 public reports- Displayed batches
- 3
- Named labs
- 2
- Quantity shown
- 2
Melanotan II
3 public reports- Displayed batches
- 3
- Named labs
- 2
- Quantity shown
- 1
Semax
3 public reports- Displayed batches
- 3
- Named labs
- 3
- Quantity shown
- 2
More public files can make a seller's documentation easier to inspect, but volume alone does not prove sampling independence, analytical quality, inventory representation, or product safety.
Search all 101 public report routes →Peptide Search Trends 2026
184 dated Google Trends observations across 36 separate panels for core demand, emerging programs, research names, search intent, and high-index countries.
02Current FDA meeting trackerFDA peptide vote results: July 23-24
14 form-level results are recorded, with 12 recommending inclusion and 2 recommending against inclusion. Check exact tallies, both official broadcasts, 19 source records, and the final-action boundary.
03Global verification report2026 Global Peptide Verification Index
1722 compound-country checks across 42 countries, with 138 identity, status, product, seller, and supply source URLs.
04Provider market scan2026 Peptide Provider Market Scan
16 researched candidates, 4 priority audits, a corrected seven-provider transparency pilot, open source routes, and no active badges.
05US benchmark reportUS research peptide price benchmarks
Availability-aware lows, medians, price spreads, vendor concentration, and document-access patterns from the current 78-row snapshot.
06Dated price movementUS research peptide price tracker
14 verified exact-product changes with previous and current list prices, percentage movement, repeated-check counts, publication availability, current market ranges, and open data.
07Open datasetInspect every source record
Browse or download the global country index, regional access records, and price data with the definitions, dates, and source routes attached.
08Vendor evidence indexCompare the sellers behind the rows
See the matched product footprint, shipping policy, document route, observations, and first-party evidence for each tracked vendor.
09Interactive methodRebuild a landed-cost comparison
Add vial count, shipping, and mandatory fees to compare two baskets by total cost per nominal milligram.
10Publisher kitCite or embed the findings
Copy a source-linked statistic embed, download the open rows, use a suggested citation, or contact the editorial desk for a data request.
11Official source directoryFind the regulator behind the country claim
Search 99 official medicine, pharmacy, facility, safety, and supply routes across 42 countries, with open CSV and JSON files.